JAK2 and myelodysplastic syndrome: For instance, MDS-SF3B1 that acquires a JAK2 mutation with resulting thrombocytosis is re-classified as MDS/MPN-SF3B1 according to the WHO-HAEM5, while it remains MDS-SF3B1 in the ICC.